Corrigendum to “The expression of stem cell protein Piwil2 and piR-932 in breast cancer” [Surg. Oncol. (2013) 22(4) 217-23]

IF 2.4 4区医学 Q3 ONCOLOGY

Surgical Oncology-Oxford Pub Date : 2025-03-27 DOI:10.1016/j.suronc.2025.102214

Hao Zhang , Yuan Ren , Huanming Xu , Deyan Pang , Chao Duan , Caigang Liu

引用次数: 0

查看原文本刊更多论文

“干细胞蛋白Piwil2和piR-932在乳腺癌中的表达”的更正[外科肿瘤学]。（2013） 22(4) 217-23]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgical Oncology-Oxford 医学-外科

CiteScore

4.50

自引率

0.00%

发文量

169

审稿时长

38 days

期刊介绍： Surgical Oncology is a peer reviewed journal publishing review articles that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive Reviews that examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.